Author:
Ballerini P,Busson M,Fasola S,van den Akker J,Lapillonne H,Romana S P,Marynen P,Bernard O A,Landman-Parker J,Berger R
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference16 articles.
1. Bernard OA, Busson-Le Coniat M, Ballerini P, Mauchauffé M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2002; 15: 1495–1504.
2. Berger R, Dastugue N, Busson M, van den Akker J, Pérot C, Ballerini P, et al., on behalf of the Groupe Français e Cytogénétique Hématologique (GFCH). t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukaemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). Leukemia 2003; 17: 1851–1857.
3. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Leukemia 2002; 100: 991–996.
4. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75–87.
5. Cavé H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, et al., for the EORTC-CLG. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004; 103: 442–450.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献